Ian Walters, Portage Biotech CEO
Low-profile biotech led by Bristol Myers vets grabs a suite of adenosine receptor antagonists via tiny buyout
A small biotech with big immunotherapy dreams out of Westport, CT, is jumping into the adenosine pathway with both feet.
Portage Biotech — which is led …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
